CRYPTOCOCCAL MENINGITIS
Clinical trials for CRYPTOCOCCAL MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new CRYPTOCOCCAL MENINGITIS trials appear
Sign up with your email to follow new studies for CRYPTOCOCCAL MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope against a deadly brain infection: large trial tests safer antifungals
Disease control Recruiting nowThis large platform trial is testing new antifungal drug combinations for cryptococcal meningitis, a severe brain infection that is fatal without treatment and common in people with HIV. The study will enroll 2,000 participants across multiple sites to compare a newer oral drug, …
Matched conditions: CRYPTOCOCCAL MENINGITIS
Phase: PHASE2, PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a single shot stop deadly meningitis in HIV patients?
Disease control Recruiting nowThis study tests whether adding one dose of a stronger antifungal drug (liposomal amphotericin) to the standard treatment (fluconazole) can prevent cryptococcal meningitis in HIV-positive adults who test positive for the fungus but have no symptoms. About 356 participants in Ugan…
Matched conditions: CRYPTOCOCCAL MENINGITIS
Phase: PHASE2, PHASE3 • Sponsor: Makerere University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Why do healthy people get this fungal infection? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at 800 healthy adults who have cryptococcosis, a fungal infection that usually only harms people with weak immune systems. Researchers want to learn why these otherwise healthy people get sick, how their immune system responds, and how the disease progresses over…
Matched conditions: CRYPTOCOCCAL MENINGITIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists launch Long-Term study to unravel mysterious immune condition
Knowledge-focused Recruiting nowThis study follows 950 people with idiopathic CD4+ lymphocytopenia (ICL), a rare condition where low CD4+ white blood cells raise infection risk. Researchers will track participants for up to 10 years, collecting medical history, blood samples, and infection data. The goal is to …
Matched conditions: CRYPTOCOCCAL MENINGITIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC